A photo of David Haslam.

Director, Antimicrobial Stewardship Program

Director, Microbial Genomics and Metagenomics Laboratory

Associate Professor, UC Department of Pediatrics

513-803-1170

Board Certified

"I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility."

My Biography & Research

Biography

I was influenced by my father, who was a pediatrician and took great satisfaction in caring for children. As a pediatric infectious disease specialist, I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.

In my practice, I try to be flexible by coordinating my patients’ appointments with those of other providers when possible. I’m committed to providing continuity and to being accessible between visits.

I’m the director of the Antimicrobial Stewardship Program and the Microbial Genomics and Metagenomics Laboratory. I've received several teaching and research awards, including the Pediatric Infectious Disease Society Young Investigator Award.

The main focus of my research is on the microbiome, which is the community of bacteria, viruses, fungi and other organisms that live on the human body. The goal is to understand how the microbiome influences disease and contributes to health in children. A healthy microbiome helps protect against infection, allergy, gastrointestinal diseases, heart disease, diabetes and diseases of premature infants.

In my free time, I enjoy riding my bike.

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Infectious Diseases, Autoimmune Liver Disease

Research Divisions

Infectious Diseases



Blog Posts

Antibiotics Are Not Always the Answer

BlogHealthy Living

Antibiotics Are Not Always the Answer

By David B. Haslam, MD3/2/2018

My Locations

My Education

MD: University of Calgary, Calgary, Alberta.

Rotating Internship: McGill University, Montreal, Quebec.

Residency: University of Ottawa, Ottawa, Quebec.

Fellowship: Washington University School of Medicine, St. Louis, MO.

My Publications

Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice. Jose, S; Mukherjee, A; Horrigan, O; Setchell, KD R; Zhang, W; Moreno-Fernandez, ME; Andersen, H; Sharma, D; Haslam, DB; Divanovic, S; et al. Mucosal Immunology. 2021; 14:500-510.

A painless erythematous swelling of the external ear as a manifestation of Lyme disease: a case report. Remiker, A; Haslam, D; Kalfa, TA. Journal of Medical Case Reports. 2020; 14.

Simultaneous skin biome and keratinocyte genomic capture reveals microbiome differences by depth of sampling. Stevens, ML; Gonzalez, T; Schauberger, E; Baatyrbek kyzy, A; Andersen, H; Spagna, D; Kalra, MK; Martin, LJ; Haslam, D; Herr, AB; et al. Journal of Allergy and Clinical Immunology. 2020; 146:1442-1445.

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). Sturchio, A; Marsili, L; Vizcarra, JA; Dwivedi, AK; Kauffman, MA; Duker, AP; Lu, P; Pauciulo, MW; Wissel, BD; Hill, EJ; et al. Frontiers in Aging Neuroscience. 2020; 12.

Microbiota-derived metabolite promotes HDAC3 activity in the gut. Wu, S; Hashimoto-Hill, S; Woo, V; Eshleman, EM; Whitt, J; Engleman, L; Karns, R; Denson, LA; Haslam, DB; Alenghat, T. Nature: New biology. 2020; 586:108-112.

Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial. Badia, P; Andersen, H; Haslam, D; Nelson, AS; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; Hickey, V; et al. Biology of Blood and Marrow Transplantation. 2020; 26:1704-1710.

Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Hellmann, J; Andersen, H; Fei, L; Linn, A; Bezold, R; Lake, K; Jackson, K; Meyer, D; Dirksing, K; Bonkowski, E; et al. Inflammatory Bowel Diseases. 2020; 26:1212-1221.

Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications. Young, J; Dahale, D; Demmel, K; O'Brien, M; Geller, J; Courter, J; Haslam, DB; Danziger-Isakov, L; Goldstein, SL. Pediatric Blood and Cancer. 2020; 67.

Prediction of Antimicrobial Resistance in Gram-Negative Bacteria From Whole-Genome Sequencing Data. Van Camp, P; Haslam, DB; Porollo, A. Frontiers in Microbiology. 2020; 11.

Analysis of chlorhexidine gluconate in skin using tape stripping and ultrahigh-performance liquid chromatography-tandem mass spectrometry. Zhao, X; Schaffzin, JK; Carson, J; Ankrum, A; Dobrzykowski, E; Haslam, DB; Dandoy, CE; Setchell, KD R. Journal of Pharmaceutical and Biomedical Analysis. 2020; 183.